dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs1482150734
Current Build 156
Released September 21, 2022
- Organism
- Homo sapiens
- Position
-
chr5:103017381 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- G>A
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
-
A=0.000008 (2/264690, TOPMED)A=0.000029 (4/140242, GnomAD)A=0.00000 (0/14050, ALFA)
- Clinical Significance
- Not Reported in ClinVar
- Gene : Consequence
- PAM : Synonymous Variant
- Publications
- 0 citations
- Genomic View
- See rs on genome
ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.
Release Version: 20231103111315
| Population | Group | Sample Size | Ref Allele | Alt Allele | Ref HMOZ | Alt HMOZ | HTRZ | HWEP |
|---|---|---|---|---|---|---|---|---|
| Total | Global | 14050 | G=1.00000 | A=0.00000 | 1.0 | 0.0 | 0.0 | N/A |
| European | Sub | 9690 | G=1.0000 | A=0.0000 | 1.0 | 0.0 | 0.0 | N/A |
| African | Sub | 2898 | G=1.0000 | A=0.0000 | 1.0 | 0.0 | 0.0 | N/A |
| African Others | Sub | 114 | G=1.000 | A=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| African American | Sub | 2784 | G=1.0000 | A=0.0000 | 1.0 | 0.0 | 0.0 | N/A |
| Asian | Sub | 112 | G=1.000 | A=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| East Asian | Sub | 86 | G=1.00 | A=0.00 | 1.0 | 0.0 | 0.0 | N/A |
| Other Asian | Sub | 26 | G=1.00 | A=0.00 | 1.0 | 0.0 | 0.0 | N/A |
| Latin American 1 | Sub | 146 | G=1.000 | A=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| Latin American 2 | Sub | 610 | G=1.000 | A=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| South Asian | Sub | 98 | G=1.00 | A=0.00 | 1.0 | 0.0 | 0.0 | N/A |
| Other | Sub | 496 | G=1.000 | A=0.000 | 1.0 | 0.0 | 0.0 | N/A |
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
Download| Study | Population | Group | Sample Size | Ref Allele | Alt Allele |
|---|---|---|---|---|---|
| TopMed | Global | Study-wide | 264690 | G=0.999992 | A=0.000008 |
| gnomAD - Genomes | Global | Study-wide | 140242 | G=0.999971 | A=0.000029 |
| gnomAD - Genomes | European | Sub | 75938 | G=1.00000 | A=0.00000 |
| gnomAD - Genomes | African | Sub | 42032 | G=0.99990 | A=0.00010 |
| gnomAD - Genomes | American | Sub | 13664 | G=1.00000 | A=0.00000 |
| gnomAD - Genomes | Ashkenazi Jewish | Sub | 3324 | G=1.0000 | A=0.0000 |
| gnomAD - Genomes | East Asian | Sub | 3130 | G=1.0000 | A=0.0000 |
| gnomAD - Genomes | Other | Sub | 2154 | G=1.0000 | A=0.0000 |
| Allele Frequency Aggregator | Total | Global | 14050 | G=1.00000 | A=0.00000 |
| Allele Frequency Aggregator | European | Sub | 9690 | G=1.0000 | A=0.0000 |
| Allele Frequency Aggregator | African | Sub | 2898 | G=1.0000 | A=0.0000 |
| Allele Frequency Aggregator | Latin American 2 | Sub | 610 | G=1.000 | A=0.000 |
| Allele Frequency Aggregator | Other | Sub | 496 | G=1.000 | A=0.000 |
| Allele Frequency Aggregator | Latin American 1 | Sub | 146 | G=1.000 | A=0.000 |
| Allele Frequency Aggregator | Asian | Sub | 112 | G=1.000 | A=0.000 |
| Allele Frequency Aggregator | South Asian | Sub | 98 | G=1.00 | A=0.00 |
Help
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
Genomic Placements
| Sequence name | Change |
|---|---|
| GRCh38.p14 chr 5 | NC_000005.10:g.103017381G>A |
| GRCh37.p13 chr 5 | NC_000005.9:g.102353085G>A |
| PAM RefSeqGene | NG_029444.2:g.267599G>A |
Gene: PAM, peptidylglycine alpha-amidating monooxygenase
(plus strand)
| Molecule type | Change | Amino acid[Codon] | SO Term |
|---|---|---|---|
| PAM transcript variant 2 | NM_138766.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform b precursor | NP_620121.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 3 | NM_138821.2:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform c precursor | NP_620176.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 4 | NM_138822.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform d precursor | NP_620177.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 7 | NM_001319943.1:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform f precursor | NP_001306872.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 17 | NM_001364590.2:c.2151G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform o | NP_001351519.1:p.Val717= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 10 | NM_001364583.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform h precursor | NP_001351512.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 18 | NM_001364591.2:c.2112G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform p precursor | NP_001351520.1:p.Val704= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 20 | NM_001364593.2:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform r precursor | NP_001351522.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 19 | NM_001364592.2:c.2112G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform q precursor | NP_001351521.1:p.Val704= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 14 | NM_001364587.2:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform l precursor | NP_001351516.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 15 | NM_001364588.2:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform m precursor | NP_001351517.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 12 | NM_001364585.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform j precursor | NP_001351514.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 9 | NM_001364582.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform g precursor | NP_001351511.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 13 | NM_001364586.2:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform k precursor | NP_001351515.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 21 | NM_001364594.2:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform s precursor | NP_001351523.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 16 | NM_001364589.2:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform n precursor | NP_001351518.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 11 | NM_001364584.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform i precursor | NP_001351513.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 5 | NM_001177306.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform e preproprotein | NP_001170777.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 1 | NM_000919.4:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform a precursor | NP_000910.2:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant 6 | NR_033440.1:n.2694G>A | N/A | Non Coding Transcript Variant |
| PAM transcript variant 8 | NR_157231.1:n. | N/A | Genic Downstream Transcript Variant |
| PAM transcript variant X24 |
XM_017009511.3:c.2386-240… XM_017009511.3:c.2386-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X25 |
XM_024446080.2:c.2386-240… XM_024446080.2:c.2386-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X29 |
XM_024446081.2:c.2386-240… XM_024446081.2:c.2386-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X22 |
XM_047417246.1:c.2386-240… XM_047417246.1:c.2386-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X23 |
XM_047417247.1:c.2386-240… XM_047417247.1:c.2386-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X27 |
XM_047417249.1:c.2332-240… XM_047417249.1:c.2332-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X28 |
XM_047417250.1:c.2332-240… XM_047417250.1:c.2332-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X30 |
XM_047417251.1:c.2332-240… XM_047417251.1:c.2332-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X34 |
XM_047417253.1:c.2011-240… XM_047417253.1:c.2011-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X35 |
XM_047417254.1:c.2011-240… XM_047417254.1:c.2011-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X36 |
XM_047417255.1:c.2011-240… XM_047417255.1:c.2011-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X37 |
XM_047417256.1:c.2011-240… XM_047417256.1:c.2011-2409G>A |
N/A | Intron Variant |
| PAM transcript variant X1 | XM_024446066.2:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X1 | XP_024301834.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X2 | XM_011543419.4:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X1 | XP_011541721.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X3 | XM_017009495.3:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X2 | XP_016864984.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X4 | XM_017009496.3:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X3 | XP_016864985.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X5 | XM_017009497.3:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X4 | XP_016864986.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X6 | XM_047417240.1:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X5 | XP_047273196.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X7 | XM_024446069.2:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X6 | XP_024301837.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X8 | XM_047417241.1:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X7 | XP_047273197.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X9 | XM_024446070.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X8 | XP_024301838.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X10 | XM_047417242.1:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X9 | XP_047273198.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X11 | XM_017009502.3:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X10 | XP_016864991.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X12 | XM_024446072.2:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X11 | XP_024301840.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X13 | XM_047417243.1:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X12 | XP_047273199.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X14 | XM_024446074.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X13 | XP_024301842.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X15 | XM_017009505.3:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X13 | XP_016864994.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X16 | XM_024446075.2:c.2433G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X14 | XP_024301843.1:p.Val811= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X17 | XM_024446076.2:c.2379G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X15 | XP_024301844.1:p.Val793= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X18 | XM_017009507.3:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X16 | XP_016864996.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X19 | XM_024446078.2:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X17 | XP_024301846.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X20 | XM_047417244.1:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X17 | XP_047273200.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X21 | XM_047417245.1:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X18 | XP_047273201.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X26 | XM_047417248.1:c.2151G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X23 | XP_047273204.1:p.Val717= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X31 | XM_047417252.1:c.1830G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X28 | XP_047273208.1:p.Val610= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X32 | XM_024446084.2:c.2058G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X29 | XP_024301852.1:p.Val686= | V (Val) > V (Val) | Synonymous Variant |
| PAM transcript variant X33 | XM_024446085.2:c.2205G>A | V [GTG] > V [GTA] | Coding Sequence Variant |
| peptidyl-glycine alpha-amidating monooxygenase isoform X30 | XP_024301853.1:p.Val735= | V (Val) > V (Val) | Synonymous Variant |
Help
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
Not Reported in ClinVar
Help
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
| Placement | G= | A |
|---|---|---|
| GRCh38.p14 chr 5 | NC_000005.10:g.103017381= | NC_000005.10:g.103017381G>A |
| GRCh37.p13 chr 5 | NC_000005.9:g.102353085= | NC_000005.9:g.102353085G>A |
| PAM RefSeqGene | NG_029444.2:g.267599= | NG_029444.2:g.267599G>A |
| PAM transcript variant 1 | NM_000919.4:c.2379= | NM_000919.4:c.2379G>A |
| PAM transcript variant 1 | NM_000919.3:c.2379= | NM_000919.3:c.2379G>A |
| PAM transcript variant 10 | NM_001364583.2:c.2379= | NM_001364583.2:c.2379G>A |
| PAM transcript variant 10 | NM_001364583.1:c.2379= | NM_001364583.1:c.2379G>A |
| PAM transcript variant 11 | NM_001364584.2:c.2379= | NM_001364584.2:c.2379G>A |
| PAM transcript variant 11 | NM_001364584.1:c.2379= | NM_001364584.1:c.2379G>A |
| PAM transcript variant 9 | NM_001364582.2:c.2379= | NM_001364582.2:c.2379G>A |
| PAM transcript variant 9 | NM_001364582.1:c.2379= | NM_001364582.1:c.2379G>A |
| PAM transcript variant 17 | NM_001364590.2:c.2151= | NM_001364590.2:c.2151G>A |
| PAM transcript variant 17 | NM_001364590.1:c.2151= | NM_001364590.1:c.2151G>A |
| PAM transcript variant 12 | NM_001364585.2:c.2379= | NM_001364585.2:c.2379G>A |
| PAM transcript variant 12 | NM_001364585.1:c.2379= | NM_001364585.1:c.2379G>A |
| PAM transcript variant 2 | NM_138766.2:c.2379= | NM_138766.2:c.2379G>A |
| PAM transcript variant 4 | NM_138822.2:c.2379= | NM_138822.2:c.2379G>A |
| PAM transcript variant 13 | NM_001364586.2:c.2058= | NM_001364586.2:c.2058G>A |
| PAM transcript variant 13 | NM_001364586.1:c.2058= | NM_001364586.1:c.2058G>A |
| PAM transcript variant 14 | NM_001364587.2:c.2058= | NM_001364587.2:c.2058G>A |
| PAM transcript variant 14 | NM_001364587.1:c.2058= | NM_001364587.1:c.2058G>A |
| PAM transcript variant 15 | NM_001364588.2:c.2058= | NM_001364588.2:c.2058G>A |
| PAM transcript variant 15 | NM_001364588.1:c.2058= | NM_001364588.1:c.2058G>A |
| PAM transcript variant 3 | NM_138821.2:c.2058= | NM_138821.2:c.2058G>A |
| PAM transcript variant 16 | NM_001364589.2:c.2058= | NM_001364589.2:c.2058G>A |
| PAM transcript variant 16 | NM_001364589.1:c.2058= | NM_001364589.1:c.2058G>A |
| PAM transcript variant 18 | NM_001364591.2:c.2112= | NM_001364591.2:c.2112G>A |
| PAM transcript variant 18 | NM_001364591.1:c.2112= | NM_001364591.1:c.2112G>A |
| PAM transcript variant 19 | NM_001364592.2:c.2112= | NM_001364592.2:c.2112G>A |
| PAM transcript variant 19 | NM_001364592.1:c.2112= | NM_001364592.1:c.2112G>A |
| PAM transcript variant 20 | NM_001364593.2:c.2058= | NM_001364593.2:c.2058G>A |
| PAM transcript variant 20 | NM_001364593.1:c.2058= | NM_001364593.1:c.2058G>A |
| PAM transcript variant 21 | NM_001364594.2:c.2058= | NM_001364594.2:c.2058G>A |
| PAM transcript variant 21 | NM_001364594.1:c.2058= | NM_001364594.1:c.2058G>A |
| PAM transcript variant 5 | NM_001177306.2:c.2379= | NM_001177306.2:c.2379G>A |
| PAM transcript variant 5 | NM_001177306.1:c.2379= | NM_001177306.1:c.2379G>A |
| PAM transcript variant 7 | NM_001319943.1:c.2433= | NM_001319943.1:c.2433G>A |
| PAM transcript variant 6 | NR_033440.1:n.2694= | NR_033440.1:n.2694G>A |
| PAM transcript variant X2 | XM_011543419.4:c.2433= | XM_011543419.4:c.2433G>A |
| PAM transcript variant X2 | XM_011543419.3:c.2433= | XM_011543419.3:c.2433G>A |
| PAM transcript variant X1 | XM_011543419.2:c.2433= | XM_011543419.2:c.2433G>A |
| PAM transcript variant X2 | XM_011543419.1:c.2433= | XM_011543419.1:c.2433G>A |
| PAM transcript variant X3 | XM_017009495.3:c.2433= | XM_017009495.3:c.2433G>A |
| PAM transcript variant X3 | XM_017009495.2:c.2433= | XM_017009495.2:c.2433G>A |
| PAM transcript variant X2 | XM_017009495.1:c.2433= | XM_017009495.1:c.2433G>A |
| PAM transcript variant X4 | XM_017009496.3:c.2433= | XM_017009496.3:c.2433G>A |
| PAM transcript variant X4 | XM_017009496.2:c.2433= | XM_017009496.2:c.2433G>A |
| PAM transcript variant X3 | XM_017009496.1:c.2433= | XM_017009496.1:c.2433G>A |
| PAM transcript variant X11 | XM_017009502.3:c.2433= | XM_017009502.3:c.2433G>A |
| PAM transcript variant X13 | XM_017009502.2:c.2433= | XM_017009502.2:c.2433G>A |
| PAM transcript variant X9 | XM_017009502.1:c.2433= | XM_017009502.1:c.2433G>A |
| PAM transcript variant X5 | XM_017009497.3:c.2379= | XM_017009497.3:c.2379G>A |
| PAM transcript variant X6 | XM_017009497.2:c.2379= | XM_017009497.2:c.2379G>A |
| PAM transcript variant X4 | XM_017009497.1:c.2379= | XM_017009497.1:c.2379G>A |
| PAM transcript variant X15 | XM_017009505.3:c.2379= | XM_017009505.3:c.2379G>A |
| PAM transcript variant X18 | XM_017009505.2:c.2379= | XM_017009505.2:c.2379G>A |
| PAM transcript variant X12 | XM_017009505.1:c.2379= | XM_017009505.1:c.2379G>A |
| PAM transcript variant X18 | XM_017009507.3:c.2058= | XM_017009507.3:c.2058G>A |
| PAM transcript variant X22 | XM_017009507.2:c.2058= | XM_017009507.2:c.2058G>A |
| PAM transcript variant X14 | XM_017009507.1:c.2058= | XM_017009507.1:c.2058G>A |
| PAM transcript variant X1 | XM_024446066.2:c.2433= | XM_024446066.2:c.2433G>A |
| PAM transcript variant X1 | XM_024446066.1:c.2433= | XM_024446066.1:c.2433G>A |
| PAM transcript variant X7 | XM_024446069.2:c.2433= | XM_024446069.2:c.2433G>A |
| PAM transcript variant X8 | XM_024446069.1:c.2433= | XM_024446069.1:c.2433G>A |
| PAM transcript variant X9 | XM_024446070.2:c.2379= | XM_024446070.2:c.2379G>A |
| PAM transcript variant X11 | XM_024446070.1:c.2379= | XM_024446070.1:c.2379G>A |
| PAM transcript variant X12 | XM_024446072.2:c.2433= | XM_024446072.2:c.2433G>A |
| PAM transcript variant X14 | XM_024446072.1:c.2433= | XM_024446072.1:c.2433G>A |
| PAM transcript variant X16 | XM_024446075.2:c.2433= | XM_024446075.2:c.2433G>A |
| PAM transcript variant X19 | XM_024446075.1:c.2433= | XM_024446075.1:c.2433G>A |
| PAM transcript variant X14 | XM_024446074.2:c.2379= | XM_024446074.2:c.2379G>A |
| PAM transcript variant X17 | XM_024446074.1:c.2379= | XM_024446074.1:c.2379G>A |
| PAM transcript variant X17 | XM_024446076.2:c.2379= | XM_024446076.2:c.2379G>A |
| PAM transcript variant X20 | XM_024446076.1:c.2379= | XM_024446076.1:c.2379G>A |
| PAM transcript variant X19 | XM_024446078.2:c.2058= | XM_024446078.2:c.2058G>A |
| PAM transcript variant X23 | XM_024446078.1:c.2058= | XM_024446078.1:c.2058G>A |
| PAM transcript variant X32 | XM_024446084.2:c.2058= | XM_024446084.2:c.2058G>A |
| PAM transcript variant X36 | XM_024446084.1:c.2058= | XM_024446084.1:c.2058G>A |
| PAM transcript variant X33 | XM_024446085.2:c.2205= | XM_024446085.2:c.2205G>A |
| PAM transcript variant X37 | XM_024446085.1:c.2205= | XM_024446085.1:c.2205G>A |
| PAM transcript variant X8 | XM_047417241.1:c.2433= | XM_047417241.1:c.2433G>A |
| PAM transcript variant X10 | XM_047417242.1:c.2379= | XM_047417242.1:c.2379G>A |
| PAM transcript variant X21 | XM_047417245.1:c.2058= | XM_047417245.1:c.2058G>A |
| PAM transcript variant X6 | XM_047417240.1:c.2379= | XM_047417240.1:c.2379G>A |
| PAM transcript variant X13 | XM_047417243.1:c.2379= | XM_047417243.1:c.2379G>A |
| PAM transcript variant X20 | XM_047417244.1:c.2058= | XM_047417244.1:c.2058G>A |
| PAM transcript variant X26 | XM_047417248.1:c.2151= | XM_047417248.1:c.2151G>A |
| PAM transcript variant X31 | XM_047417252.1:c.1830= | XM_047417252.1:c.1830G>A |
| peptidyl-glycine alpha-amidating monooxygenase isoform a precursor | NP_000910.2:p.Val793= | NP_000910.2:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform h precursor | NP_001351512.1:p.Val793= | NP_001351512.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform i precursor | NP_001351513.1:p.Val793= | NP_001351513.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform g precursor | NP_001351511.1:p.Val793= | NP_001351511.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform o | NP_001351519.1:p.Val717= | NP_001351519.1:p.Val717= |
| peptidyl-glycine alpha-amidating monooxygenase isoform j precursor | NP_001351514.1:p.Val793= | NP_001351514.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform b precursor | NP_620121.1:p.Val793= | NP_620121.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform d precursor | NP_620177.1:p.Val793= | NP_620177.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform k precursor | NP_001351515.1:p.Val686= | NP_001351515.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform l precursor | NP_001351516.1:p.Val686= | NP_001351516.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform m precursor | NP_001351517.1:p.Val686= | NP_001351517.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform c precursor | NP_620176.1:p.Val686= | NP_620176.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform n precursor | NP_001351518.1:p.Val686= | NP_001351518.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform p precursor | NP_001351520.1:p.Val704= | NP_001351520.1:p.Val704= |
| peptidyl-glycine alpha-amidating monooxygenase isoform q precursor | NP_001351521.1:p.Val704= | NP_001351521.1:p.Val704= |
| peptidyl-glycine alpha-amidating monooxygenase isoform r precursor | NP_001351522.1:p.Val686= | NP_001351522.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform s precursor | NP_001351523.1:p.Val686= | NP_001351523.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform e preproprotein | NP_001170777.1:p.Val793= | NP_001170777.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform f precursor | NP_001306872.1:p.Val811= | NP_001306872.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X1 | XP_011541721.1:p.Val811= | XP_011541721.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X2 | XP_016864984.1:p.Val811= | XP_016864984.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X3 | XP_016864985.1:p.Val811= | XP_016864985.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X10 | XP_016864991.1:p.Val811= | XP_016864991.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X4 | XP_016864986.1:p.Val793= | XP_016864986.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X13 | XP_016864994.1:p.Val793= | XP_016864994.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X16 | XP_016864996.1:p.Val686= | XP_016864996.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X1 | XP_024301834.1:p.Val811= | XP_024301834.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X6 | XP_024301837.1:p.Val811= | XP_024301837.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X8 | XP_024301838.1:p.Val793= | XP_024301838.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X11 | XP_024301840.1:p.Val811= | XP_024301840.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X14 | XP_024301843.1:p.Val811= | XP_024301843.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X13 | XP_024301842.1:p.Val793= | XP_024301842.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X15 | XP_024301844.1:p.Val793= | XP_024301844.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X17 | XP_024301846.1:p.Val686= | XP_024301846.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X29 | XP_024301852.1:p.Val686= | XP_024301852.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X30 | XP_024301853.1:p.Val735= | XP_024301853.1:p.Val735= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X7 | XP_047273197.1:p.Val811= | XP_047273197.1:p.Val811= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X9 | XP_047273198.1:p.Val793= | XP_047273198.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X18 | XP_047273201.1:p.Val686= | XP_047273201.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X5 | XP_047273196.1:p.Val793= | XP_047273196.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X12 | XP_047273199.1:p.Val793= | XP_047273199.1:p.Val793= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X17 | XP_047273200.1:p.Val686= | XP_047273200.1:p.Val686= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X23 | XP_047273204.1:p.Val717= | XP_047273204.1:p.Val717= |
| peptidyl-glycine alpha-amidating monooxygenase isoform X28 | XP_047273208.1:p.Val610= | XP_047273208.1:p.Val610= |
| PAM transcript variant X24 | XM_017009511.3:c.2386-2409= | XM_017009511.3:c.2386-2409G>A |
| PAM transcript variant X25 | XM_024446080.2:c.2386-2409= | XM_024446080.2:c.2386-2409G>A |
| PAM transcript variant X29 | XM_024446081.2:c.2386-2409= | XM_024446081.2:c.2386-2409G>A |
| PAM transcript variant X22 | XM_047417246.1:c.2386-2409= | XM_047417246.1:c.2386-2409G>A |
| PAM transcript variant X23 | XM_047417247.1:c.2386-2409= | XM_047417247.1:c.2386-2409G>A |
| PAM transcript variant X27 | XM_047417249.1:c.2332-2409= | XM_047417249.1:c.2332-2409G>A |
| PAM transcript variant X28 | XM_047417250.1:c.2332-2409= | XM_047417250.1:c.2332-2409G>A |
| PAM transcript variant X30 | XM_047417251.1:c.2332-2409= | XM_047417251.1:c.2332-2409G>A |
| PAM transcript variant X34 | XM_047417253.1:c.2011-2409= | XM_047417253.1:c.2011-2409G>A |
| PAM transcript variant X35 | XM_047417254.1:c.2011-2409= | XM_047417254.1:c.2011-2409G>A |
| PAM transcript variant X36 | XM_047417255.1:c.2011-2409= | XM_047417255.1:c.2011-2409G>A |
| PAM transcript variant X37 | XM_047417256.1:c.2011-2409= | XM_047417256.1:c.2011-2409G>A |
Help
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
3 SubSNP,
3 Frequency
submissions
| No | Submitter | Submission ID | Date (Build) |
|---|---|---|---|
| 1 | GNOMAD | ss2747426473 | Nov 08, 2017 (151) |
| 2 | GNOMAD | ss2828299590 | Nov 08, 2017 (151) |
| 3 | TOPMED | ss4671111985 | Apr 26, 2021 (155) |
| 4 | gnomAD - Genomes | NC_000005.10 - 103017381 | Apr 26, 2021 (155) |
| 5 | TopMed | NC_000005.10 - 103017381 | Apr 26, 2021 (155) |
| 6 | ALFA | NC_000005.10 - 103017381 | Apr 26, 2021 (155) |
Help
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
Help
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
No publications for rs1482150734
Help
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genome context:
Select flank length:
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.